Investment
Features
FeesSafety
Academy
More
Pluang+

Compare United Airlines Holdings Inc (UAL) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance

United Airlines Holdings IncTrade
Vertex Pharmaceuticals IncorporatedTrade

Price performance (Past 24H)

Key statistics

United Airlines Holdings Inc vs Vertex Pharmaceuticals Incorporated — how do they compare? United Airlines Holdings Inc trades at $118.05 (market cap $38.15B), while Vertex Pharmaceuticals Incorporated trades at $481.09 (market cap $121.95B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 3.2× United Airlines Holdings Inc's market cap. Which is the better fit depends on your goals.

UALVRTX
Market Cap
$38.15B$121.95B
Sector
IndustrialsHealth
52-Week High
$136.11$529.59
52-Week Low
$84.57$366.54
Enterprise Value
$55.18B$116.69B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About United Airlines Holdings Inc

United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.

Read more on UAL

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Read more on VRTX